Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Jeffrey H. Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6740-3670; OpenAlex author ID A5010974431. Sources: OpenAlex.

Their work

Papers
16 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
59
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 4 papers · 2020: none · 2021: none · 2022: 3 papers

Papers 16

  1. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Co-author DOI 10.1002/cncy.22533↗
  2. Preoperative biliary drainage for pancreatic cancer. First author DOI 10.1111/den.14081↗
  3. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci151604↗
  4. Endoscopic Management of Pancreatic Cancer. Co-author DOI 10.1016/j.soc.2018.07.002↗
  5. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome Co-author DOI 10.1097/mpa.0000000000001293↗
  6. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1200/po.19.00001↗
  7. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-018-6807-9↗
  8. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Last author DOI 10.1016/j.gie.2017.12.019↗
  9. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. Co-author DOI 10.1007/s11605-016-3265-1↗
  10. The endoscopist's role in the diagnosis and management of pancreatic cancer. Co-author DOI 10.1080/17474124.2016.1176910↗
  11. Reply to BRCA2‐associated pancreatic cancer and current screening guidelines First author DOI 10.1002/cncr.29446↗
  12. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience. Last author DOI 10.1016/j.gie.2014.08.023↗
  13. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Co-author DOI 10.5754/hge11774↗
  14. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Co-author DOI 10.1016/j.rcl.2012.03.008↗
  15. Self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. First author DOI 10.3978/j.issn.2078-6891.2012.048↗
  16. Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases. Last author DOI 10.1007/s10620-011-1815-7↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Manoop S. Bhutani · 7 shared papers, 2013–2022 · strength 0.56
  2. Brian R. Weston · 6 shared papers, 2017–2022 · strength 0.53
  3. Anirban Maitra · 5 shared papers, 2017–2022 · strength 0.45
  4. William A. Ross · 6 shared papers, 2011–2022 · strength 0.43
  5. Jason B. Fleming · 7 shared papers, 2011–2022 · strength 0.41
  6. Matthew H. G. Katz · 6 shared papers, 2012–2022 · strength 0.37
  7. Fredy Nehme · 1 shared paper, 2022 · strength 0.33
  8. Priya Bhosale · 5 shared papers, 2012–2019 · strength 0.31
  9. Huamin Wang · 4 shared papers, 2017–2022 · strength 0.30
  10. Robert A. Wolff · 4 shared papers, 2017–2022 · strength 0.30
  11. Eugene Jon Koay · 4 shared papers, 2017–2022 · strength 0.30
  12. Jeffrey E. Lee · 4 shared papers, 2017–2022 · strength 0.30
  13. Gauri Rajani Varadhachary · 5 shared papers, 2011–2019 · strength 0.25
  14. Eric Peter Tamm · 4 shared papers, 2012–2019 · strength 0.23
  15. Emmanuel S. Coronel · 2 shared papers, 2018–2022 · strength 0.22
  16. Milind M. Javle · 4 shared papers, 2011–2019 · strength 0.22
  17. Florencia M. McAllister · 2 shared papers, 2019–2022 · strength 0.21
  18. Osman Ahmed · 1 shared paper, 2019 · strength 0.20
  19. Rachna T. Shroff · 3 shared papers, 2017–2019 · strength 0.19
  20. Laura R. Prakash · 3 shared papers, 2017–2019 · strength 0.19
  21. David R. Fogelman · 3 shared papers, 2017–2019 · strength 0.19
  22. Ching-Wei David Tzeng · 2 shared papers, 2019–2022 · strength 0.19
  23. Michael P. Kim · 2 shared papers, 2017–2022 · strength 0.16
  24. Qiong Gan · 1 shared paper, 2022 · strength 0.15
  25. Phillip S. Ge · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.